The Wall Street Journals Your Money Matters

What's Next for Valeant Pharmaceuticals?

2/29/2016 6:11PM     

After a postponed earnings call, can the return of chief executive Michael Pearson help Valeant Pharmaceuticals find its way out of a cloud of uncertainty?